This report expanded the genotypic spectrum of DYNC1H1 gene, and highlights the potential therapeutic option of ketogenic diet for DYNC1H1-related developmental and epileptic encephalopathy, particularly in cases refractory to ASMs. This evidence concerns the gene DYNC1H1 and developmental and epileptic encephalopathy.